Are Nanotechnological Approaches the Future of Treating Inflammatory diseases?

Abstract

The current treatments for chronic inflammatory diseases cause severe side effects due to nonspecific drug accumulation. Nanotechnology opens the way to new therapeutic strategies that exploit the ability of immune cells, and especially of phagocytes, to internalize nanoparticles. The cellular uptake of nanoparticles requires specific interactions and is affected by the chemical and physical properties of the carriers. Therefore, optimizing these properties is crucial for designing nanodrugs for immunotherapy. In perspective, we discuss the nanoparticle-based approaches that have been proposed to induce tolerance in autoimmune disorders and lessen the symptoms of inflammatory diseases.

Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope

“…After systemic administration, the major clearance organs are lungs, liver, spleen, kidneys; the relationships between the biodistribution in such organs and the NCs properties are reported in Table 1. In general, for particles above the renal threshold (size > 5.5 nm) [22], the elimination is performed by tissue-resident macrophages, monocytes, and dendritic cells belonging to the MPS, although the role of endothelial cells has been recently reconsidered [23,24]. Table 1.…”

Nanomaterials for the Diagnosis and Treatment of Inflammatory Arthritis

“…All methods have many drawbacks such as low precision, poor image resolution, and high cost, despite the extensive use of conventional methods in the diagnosis of arthritis. However, important progress in nanomedicine has been made recently and new platforms for high precision diagnosis of inflammatory arthritis can be introduced by nanotechnology [97,98].…”

Potential of nanoparticles and nanopolymers in treatment of age-associated diseases

“…(Elsayed & Norredin, 2019). New advances in nanotechnology and nanomedicine-based strategies have led to the emergence of nanomedicine for the inflammatory disease treatments that can be directly effective in delaying aging (Table 6 ) (Rizzuto et al, 2019).…”

“…Phase I (Pearson et al, 2019) Gold nanoparticles Plaque psoriasis Phase I (Rizzuto et al, 2019) Figure 1. The cellular and molecular pathways relating to aging and age-dependent diseases.…”